Market Research Report

Global Cancer Gene Panel and Profiling Market Research Report: Forecast (2024-2029)

By Technology (Next-generation Sequencing [NGS], Polymerase Chain Reaction [PCR], Microarray, Mass Spectrometry, Others), By Application (Oncology Research, Personalized Medicine, ...Drug Development, Clinical Diagnostics), By Cancer Type (Breast Cancer, Lung Cancer, Prostrate Cancer, Colorectal Cancer, Others) , By Cell Type (Germline, Somatic), By End-User (Hospital & Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other) Read more

  • Healthcare
  • Oct 2023
  • Pages 192
  • Report Format: PDF, Excel, PPT

Market Definition

Cancer gene panel & profiling is a genetic testing method that focuses on analyzing a specific set of genes associated with a particular condition or disease. It involves sequencing & analyzing the DNA within these selected genes to identify potential variations, mutations, or alterations that may be linked to the condition under investigation. Gene profiling testing refers to the comprehensive analysis of multiple genes or gene expression patterns to gain insights into various biological processes, disease states, or responses to treatments. Both gene panel testing & gene profiling testing play crucial roles in genomics research, personalized medicine, and clinical diagnostics by providing insights into genetic variations, gene expression patterns, and their implications for health and disease.

Market Insights & Projections: Global Cancer Gene Panel and Profiling Market (2024-29):

The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29. The exponential increase in the incidence of cancer has emerged as a key driver propelling the market growth for cancer gene panels & profiling testing services. For instance, according to the Global Cancer Observatory, in 2022, there were approximately 19.3 million new cases & 10.3 million deaths due to cancer all across the globe. Breast Cancer in females surpassed lung cancer in 2020, thereby becoming the most common type of diagnosed cancer with 11.7% prevalence, followed by lung cancer at 11.4%, colon cancer at 10%, prostate cancer at 7.3%, and stomach cancer at 5.6%.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-29
CAGR (2024-2029) 15.5%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Singapore, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled 10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other
Unit Denominations USD Million/Billion

 

This surge has led to the escalating demand for advanced diagnostic testing procedures for the early detection & monitoring of cancer cases. Consequently, oncologists have progressively embraced the utilization of genetic testing methodologies such as gene panels & profiling to discern crucial factors like disease stage, hereditary predisposition, and tailored therapeutic approaches.

Moreover, the realm of genetic testing has also been observed to play a pivotal role in enabling oncologists to accurately ascertain the precise stage of cancer within patients, thereby facilitating more effective and targeted treatment strategies. Hence, to capitalize on this plethora of advantages, healthcare professionals started inclining toward genetic profiling & panel testing, which has distinctly bolstered the growth trajectory of this market.


Global Cancer Gene Panel and Profiling Market Research Report: Forecast (2024-2029)

Furthermore, the incorporation of genetic panels and profiling techniques within the realm of drug development has exerted an influence on the surge in demand for these testing services. This innovative approach opened diverse avenues within the drug development domain & facilitated the crucial task of identifying biomarkers, a fundamental step in shaping groundbreaking strategies for novel cancer treatments. In addition, numerous national governments like the US, China, and Japan, among others, are making substantial investments in robust cancer research initiatives.

These concerted efforts underscored their commitment to addressing the escalating threat of cancer while simultaneously fostering the creation of innovative & potent therapeutic regimens aimed at delivering improved outcomes for patients. Hence, the increase in research activities for cancer treatment would create an opportunity for improving the demand for cancer gene panels & profiling services in the coming years.

Global Cancer Gene Panel and Profiling Market Driver

Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.

Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:

  • In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.

As the mutations in hereditary cancer are only pinpointed to specific genes responsible for shielding the body against cancer, it led to genetic testing services coming up as a pivotal method of diagnosis. Notably, clinicians have embraced this technique with significant impact, thereby fostering substantial growth within the Cancer Gene Panel and Profiling Market.

Global Cancer Gene Panel and Profiling Market Opportunity

Rising Development of Personalized Medicine – Cancer gene panels and profiling services are projected to experience substantial growth in the future, owing to their potential efficacy in personalized cancer treatment. As gene panel and profiling services have the potential to identify patients with specific genetic characteristics that are likely to respond to various treatment methods, it is expected to broaden their market potential. This approach would improve the safety profile of cancer patients by reducing the potential for adverse effects & toxicity associated with personalized drugs.

In addition, hospitals & cancer research centers in recent years have been focussing on providing personalized treatment services to their cancer patients, especially across countries like India, the UK, etc. For instance:

  • In 2023, the UK Government and BioNTech SE entered into a memorandum of understanding (MoU), which aims to enhance cancer patients' access to cutting-edge trials & therapies in development and to extend personalized cancer treatments to more patients.

Consequently, as the provision of personalized treatment increases across the globe, the demand for cancer gene panels and profiling services would also amplify. Hence, the rising inclination toward personalized medicines would represent a significant opportunity for the Cancer Gene Panel and Profiling Market growth in the forecast years.

Global Cancer Gene Panel and Profiling Market Challenge

Data Privacy & Security Issues to Affect Market Growth – In recent years, the Cancer Gene Panel and Profiling Market has been experiencing a significant number of data breaches, which has been affecting its market growth. The cancer gene panels & profiling consist of a large volume of sensitive information about patients including their genetic makeup along with their medical history, treatment plans, and potentially familial genetic information.

Also, over the past few years, it has been observed that several cancer testing labs have experienced data breach cases, which has led to the leakage of sensitive datasets. Hence, these instances of data breaches have resulted in reducing consumer trust in genetic testing providers, which has been affecting the adoption of cancer gene panels and profiling services as well.

Global Cancer Gene Panel and Profiling Market Trend:

Rising Advancement in Next-generation Sequencing (NGS) Technology to Boost the Market – Next-generation Sequencing (NGS) is a powerful technique employed to simultaneously analyze multiple genomes, and in recent years, there has been an increasing advancement in this technology. This has been attributed to the growing prevalence of chronic & life-threatening diseases such as cancer, creating a pressing need for rapid & precise testing to guide patient treatment decisions.

With recent advancements, NGS goes beyond traditional methods by enabling the exploration of novel RNA variants & splice sites through RNA sequencing (RNA-Seq) while facilitating the quantification of mRNA for comprehensive gene expression analysis. The multifaceted capabilities of NGS technology have ignited a substantial surge in its adoption within the Cancer Gene Panel and Profiling Market, making it a prevailing trend across the global industry.

Global Cancer Gene Panel and Profiling Market (2024-29): Segmentation Analysis

The Global Cancer Gene Panel and Profiling Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024-29 at the global levels. In accordance to the analysis, the market has been further classified as:

Based on Cancer Type:

The heightened presence of Lung Cancer patients globally has widely accumulated the demand for more effective diagnostic options over the past few years. According to the International Agency for Research on Cancer (IARC), lung cancer remains the leading cause of cancer deaths, with an estimated 1.8 million deaths (18%) in 2020.

In lung cancer diagnostics, gene panel and profiling testing services offer potential steps during target drug development owing to their ability to provide precise results for the specific genetic activity of the genes. Hence, their demand has been rising among many healthcare professionals prescribing diagnostics, which has improved the Cancer Gene Panels and Profiling Market size.  

Based on End-User

  • Hospitals & Clinics
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology
  • Contract Research Organizations

Research Institutes are poised to capture the potential share of the Global Cancer Gene Panel and Profiling Market in the coming years. They play a pivotal role in advancing cancer diagnosis & the development of innovative therapies. As research institutes have been at the forefront of clinical trials & drug development, they require gene panels and profiling testing for patient assessments.

This necessitates the involvement of skilled medical professionals, including oncologists, scientists, and healthcare experts, who can safely & effectively administer these therapies. Consequently, research institutes actively seek partnerships with genetic testing providers equipped with the necessary facilities & expertise to deliver gene panels and profiling testing services. As a result, the global demand for cancer gene panels and profiling testing has been primarily driven by research institutes.

Global Cancer Gene Panel and Profiling Market (2024-29): Regional Projection

Geographically, the Global Cancer Gene Panel and Profiling Market expands across:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

North America held the largest share in the Global Cancer Gene Panels and Profiling Market. This can be attributed to substantial funding allocated to R&D initiatives, significant advancements in screening technologies, and a robust medical infrastructure, among others. For instance:

  • In 2023, the US government allocated a substantial USD 1.7 billion to the Department of Human Health and Services for dedicated cancer-related research & development.

Thus, significant investments in cancer research would further drive augmented utilization of gene panels and profiling testing services in the region, thereby positively influencing the North American Cancer Gene Panels and Profiling Market growth in the projected years.

Global Cancer Gene Panel and Profiling Industry Recent Development:

  • 2023: Neo Genomics and Massive Bio announced a collaboration to leverage their expertise in biomarker testing, data analysis, machine learning, and biomarker and genomic profiling to accomplish a significant milestone within the field of oncology.
  • 2022: Variantyx invested USD 41.5 million for its advanced genomic testing platform, with plans to target growth in precision oncology.

Gain a Competitive Edge with Our Global Cancer Gene Panel and Profiling Market Report

  • Global Cancer Gene Panel and Profiling Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
  • This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  • Global Cancer Gene Panel and Profiling Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The growth rate or CAGR of the Cancer Gene Panel and Profiling Market during 2024-29 is expected to be around 15.5%.

   A. The rising prevalence of hereditary cancer cases is expected to drive the Cancer Gene Panel and Profiling Market during 2024-29.

   A. The top players are 10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies, etc.

   A. Lung cancer is the leading cancer type in the Cancer Gene Panel and Profiling Market.

   A. North America would present growth prospects in the Cancer Gene Panel and Profiling Market during 2024-29.

   A. The advancement in NGS technology for cancer research is one of the trends shaping the growth of the Cancer Gene Panel and Profiling Market.

   A. The development of personalized medicine is the growth opportunity driving the Cancer Gene Panel and Profiling Market through 2029.

   A. Data security & privacy issues are the possible restraints affecting the growth of the Cancer Gene Panel and Profiling Market.

   A. The industry's potential end-users are research institutes, hospitals & clinics, diagnostic laboratories, and others.

Global Cancer Gene Panel and Profiling Market Research Report (2024-2029) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Genome Sequencing Revolution, 2000-2022
  5. Global Cancer Gene Panel and Profiling Clinical Trial Analysis, 2019-2023
  6. Global Cancer Gene Panel and Profiling Market Trends & Developments
  7. Global Cancer Gene Panel and Profiling Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Cancer Gene Panel and Profiling Market Regulation, Policy & Standards
  9. Global Cancer Gene Panel and Profiling Market Hotspot and Opportunities
  10. Global Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Technology
        1. Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
        2. Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
        3. Microarray- Market Size & Forecast 2019-2029, USD Million
        4. Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
        5. Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
      2. By Application
        1. Oncology Research- Market Size & Forecast 2019-2029, USD Million
        2. Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
        3. Drug Development- Market Size & Forecast 2019-2029, USD Million
        4. Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type
        1. Breast Cancer- Market Size & Forecast 2019-2029, USD Million
        2. Lung Cancer- Market Size & Forecast 2019-2029, USD Million
        3. Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
        4. Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
        5. Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type
        1. Germline - Market Size & Forecast 2019-2029, USD Million
        2. Somatic - Market Size & Forecast 2019-2029, USD Million
      5. By End-User
        1. Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
        2. Research Institutes- Market Size & Forecast 2019-2029, USD Million
        3. Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
        4. Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      7. By Company
        1. Competition Characteristics
        2. Revenue Shares & Analysis
  11. North America Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. Canada Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. Mexico Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  12. South America Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  13. Europe Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. The UK Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. France Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    6. Spain Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    7. Italy Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  14. Middle East & Africa Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. GCC
        2. South Africa
        3. Rest of Middle East & Africa
    3. GCC Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. South Africa Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  15. Asia-Pacific Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Technology- Market Size & Forecast 2019-2029, USD Million
      2. By Application- Market Size & Forecast 2019-2029, USD Million
      3. By Cancer Type- Market Size & Forecast 2019-2029, USD Million
      4. By Cell Type- Market Size & Forecast 2019-2029, USD Million
      5. By End-User-Market Size & Forecast 2019-2029, USD Million
      6. By Country
        1. China
        2. Japan
        3. South Korea
        4. India
        5. Australia
        6. Rest of Asia Pacific
    3. China Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    4. Japan Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    5. South Korea Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    6. India Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
    7. Australia Cancer Gene Panel and Profiling Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Technology- Market Size & Forecast 2019-2029, USD Million
        2. By End-User-Market Size & Forecast 2019-2029, USD Million
  16. Global Cancer Gene Panel and Profiling Market Key Strategic Imperatives for Success & Growth
  17. Competitive Outlook
    1. Company Profiles 
      1. 10x Genomics, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
      2. Caris Lifescience
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Neo genomics
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Flugent Genetics
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Centogene N.V.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Geneseeq Technology Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Variantyx
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Genetron Holdings Limited
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Laboratory Corporation of America® Holdings (LabCorp)
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. H.T. G Molecular
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Bio array Diagnostic genetic
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Biorad laboratories Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Enzo Lifesciences
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Eurofins Scientific
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Nanostring Technologies
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


Cancer Gene Panel and Profiling Market Segmentation
Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700
USD 2,960

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850
USD 3,880

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000
USD 4,800

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500
USD 5,250

Request Sample Talk to our Consultant Request Customization
Related Reports